Skip to main content
Erschienen in: Lung 1/2014

01.02.2014

Genetic Susceptibility to Lung Cancer Based on Candidate Genes in a Sample from the Mexican Mestizo Population: A Case–Control Study

verfasst von: R. Pérez-Morales, I. Méndez-Ramírez, H. Moreno-Macias, A. D. Mendoza-Posadas, O. C. Martínez-Ramírez, C. Castro-Hernández, M. E. Gonsebatt, J. Rubio

Erschienen in: Lung | Ausgabe 1/2014

Einloggen, um Zugang zu erhalten

Abstract

Background

Lung cancer (LC) is the leading cause of mortality caused by neoplasias worldwide. Although cigarette smoking is the primary cause, not all smokers develop LC. Polymorphic variations in genes associated with carcinogen metabolism, DNA repair, and cell-cycle dysregulation may alter an individual risk of developing LC. A polygenic cancer model was proposed, which considers genetic susceptibility to cancer is a global mechanism and suggests that it might be defined by the contributions of low-risk alleles in several candidate genes. This study focused on the analysis of 15 polymorphisms in 12 low-penetrance genes in a case–control study of a sample of Mexican Mestizo population.

Methods

A case–control study was performed with a total of 572 unrelated individuals, including 190 cases with a primary LC diagnosis and 382 healthy controls. The polymorphic status of the individuals was determined by TaqMan probe and RFLP techniques. The association between LC and genotype score (GS) was assessed by logistic regression.

Results

The results suggests a protective effect of the genotypes Arg/Lys of AhR rs2066853 (odds ratio [OR] 0.55, p = 0.03), Ile/Val of CYP1A1 rs1048943 (OR 0.49, p = 0.009), Tyr/His of EPHX1 rs1051740 (OR 0.53, p = 0.03), and A/A of CCND1 rs603965 (OR 0.44, p = 0.02). Analyses using the GS suggest that average cases have a larger number of risk alleles than controls (Student’s t test −4.85, p = 0.001; OR 1.25, p < 0.001).

Conclusions

Our results suggest significant differences between the GS for the cases and controls, which support the hypothesis underlying the additive and polygenic models for lung cancer risk depending on the polymorphisms in low-penetrance genes.
Literatur
2.
Zurück zum Zitat Ruíz-Godoy L, Rizo P, Sánchez F, Osornio-Vargas A, García-Cuellar C, Meneses A (2007) Mortality due to lung cancer in Mexico. Lung Cancer 58:184–190CrossRefPubMed Ruíz-Godoy L, Rizo P, Sánchez F, Osornio-Vargas A, García-Cuellar C, Meneses A (2007) Mortality due to lung cancer in Mexico. Lung Cancer 58:184–190CrossRefPubMed
3.
Zurück zum Zitat Dong L, Potter J, White E, Ulrich C, Cardon L, Peters U (2008) Genetic susceptibility to cancer: the role of polymorphism in candidate genes. JAMA 299:2423–2434PubMedCentralCrossRefPubMed Dong L, Potter J, White E, Ulrich C, Cardon L, Peters U (2008) Genetic susceptibility to cancer: the role of polymorphism in candidate genes. JAMA 299:2423–2434PubMedCentralCrossRefPubMed
4.
Zurück zum Zitat Zienolddiny S, Campa D, Lind H, Ryberg D, Skaug V, Stangeland B et al (2008) A comprehensive analysis of phase I and phase II metabolism gene polymorphisms and risk of non-small cell lung cancer in smokers. Carcinogenesis 29(6):1164–1169CrossRefPubMed Zienolddiny S, Campa D, Lind H, Ryberg D, Skaug V, Stangeland B et al (2008) A comprehensive analysis of phase I and phase II metabolism gene polymorphisms and risk of non-small cell lung cancer in smokers. Carcinogenesis 29(6):1164–1169CrossRefPubMed
5.
Zurück zum Zitat Zhang J, Gu S, Zhang P, Jia Z, Chang J (2010) ERCC2 Lys751Gln polymorphism is associated with lung cancer among Caucasians. Eur J Cancer 46:2479–2484CrossRefPubMed Zhang J, Gu S, Zhang P, Jia Z, Chang J (2010) ERCC2 Lys751Gln polymorphism is associated with lung cancer among Caucasians. Eur J Cancer 46:2479–2484CrossRefPubMed
6.
Zurück zum Zitat Lim W, Chen Y, Ali S, Chuah K, Eng P, Leong S et al (2011) Polymorphisms in inflammatory pathway genes, host factors and lung cancer risk in Chinese female never-smokers. Carcinogenesis 32(4):522–529CrossRefPubMed Lim W, Chen Y, Ali S, Chuah K, Eng P, Leong S et al (2011) Polymorphisms in inflammatory pathway genes, host factors and lung cancer risk in Chinese female never-smokers. Carcinogenesis 32(4):522–529CrossRefPubMed
7.
Zurück zum Zitat Wang X, Chorley B, Pittman G, Kleeberger S, Brothers J II, Liu G et al (2010) Genetic variation and antioxidant response genes expression in the bronchial airway epithelium of smokers at risk for lung cancer. Plos One 5(8):1–13 Wang X, Chorley B, Pittman G, Kleeberger S, Brothers J II, Liu G et al (2010) Genetic variation and antioxidant response genes expression in the bronchial airway epithelium of smokers at risk for lung cancer. Plos One 5(8):1–13
8.
Zurück zum Zitat Hosgood H III, Menashe I, Shen M, Yeager M, Yuenger J, Rajaraman P et al (2008) Pathway-based evaluation of 380 candidate genes and lung cancer susceptibility suggests the importance of the cell cycle pathway. Carcinogenesis 29:1938–1943PubMedCentralCrossRefPubMed Hosgood H III, Menashe I, Shen M, Yeager M, Yuenger J, Rajaraman P et al (2008) Pathway-based evaluation of 380 candidate genes and lung cancer susceptibility suggests the importance of the cell cycle pathway. Carcinogenesis 29:1938–1943PubMedCentralCrossRefPubMed
9.
Zurück zum Zitat Vineis P, Manuguerra M, Kavvoura F, Guarrera S, Allione A, Rosa F et al (2009) A field synopsis on low penetrance variants in DNA repair genes and cancer susceptibility. J Natl Cancer Inst 101:24–36CrossRefPubMed Vineis P, Manuguerra M, Kavvoura F, Guarrera S, Allione A, Rosa F et al (2009) A field synopsis on low penetrance variants in DNA repair genes and cancer susceptibility. J Natl Cancer Inst 101:24–36CrossRefPubMed
10.
Zurück zum Zitat Wang Y, Yang H, Li H, Li L, Wang H, Liu C et al (2009) Association between x-ray repair cross complementing group 1 codon 399 and 194 polymorphisms and lung cancer risk: a meta-analysis. Cancer Lett 285:134–140CrossRefPubMed Wang Y, Yang H, Li H, Li L, Wang H, Liu C et al (2009) Association between x-ray repair cross complementing group 1 codon 399 and 194 polymorphisms and lung cancer risk: a meta-analysis. Cancer Lett 285:134–140CrossRefPubMed
11.
Zurück zum Zitat Carlsten C, Sagoo G, Frodsham A, Burke W, Higgins J (2008) Glutathione S-transferase M1 (GSTM1) polymorphisms and lung cancer: a literature-based systematic HuGE review and meta-analysis. Am J Epidemiol 167(7):759–774CrossRefPubMed Carlsten C, Sagoo G, Frodsham A, Burke W, Higgins J (2008) Glutathione S-transferase M1 (GSTM1) polymorphisms and lung cancer: a literature-based systematic HuGE review and meta-analysis. Am J Epidemiol 167(7):759–774CrossRefPubMed
12.
Zurück zum Zitat Raimondi S, Paracchini V, Autrup H, Barros-Dios J, Benhamou S, Boffetta P et al (2006) Meta- and pooled analysis of GSTT1 and lung cancer: a HuGE-GSEC review. Am J Epidemiol 164(11):1027–1042CrossRefPubMed Raimondi S, Paracchini V, Autrup H, Barros-Dios J, Benhamou S, Boffetta P et al (2006) Meta- and pooled analysis of GSTT1 and lung cancer: a HuGE-GSEC review. Am J Epidemiol 164(11):1027–1042CrossRefPubMed
13.
Zurück zum Zitat Wang Y, Yang H, Li L, Wang H (2010) Glutathione S-transferase T1 gene deletion polymorphism and lung cancer risk in Chinese population: a meta-analysis. Cancer Epidemiol 34(5):593–597CrossRefPubMed Wang Y, Yang H, Li L, Wang H (2010) Glutathione S-transferase T1 gene deletion polymorphism and lung cancer risk in Chinese population: a meta-analysis. Cancer Epidemiol 34(5):593–597CrossRefPubMed
14.
Zurück zum Zitat Cote M, Chen W, Smith D, Benhamou S, Bouchardy C, Butkiewicz D et al (2009) Meta- and pooled analysis of GSTP1 polymorphism and lung cancer: a HuGE-GSEC review. Am J Epidemiol 169(7):802–814PubMedCentralCrossRefPubMed Cote M, Chen W, Smith D, Benhamou S, Bouchardy C, Butkiewicz D et al (2009) Meta- and pooled analysis of GSTP1 polymorphism and lung cancer: a HuGE-GSEC review. Am J Epidemiol 169(7):802–814PubMedCentralCrossRefPubMed
15.
Zurück zum Zitat Chen Z, Li Z, Niu X, Ye X, Yu Y, Lu S (2011) The effect of CYP1A1 polymorphism on the risk of lung cancer: a global meta-analysis based on 71 case–control studies. Mutagenesis 26(3):437–446CrossRefPubMed Chen Z, Li Z, Niu X, Ye X, Yu Y, Lu S (2011) The effect of CYP1A1 polymorphism on the risk of lung cancer: a global meta-analysis based on 71 case–control studies. Mutagenesis 26(3):437–446CrossRefPubMed
16.
Zurück zum Zitat Wang J, Zheng Y, Sun L, Wang L, Yu P, Li H et al (2011) CYP1A1 Ile462Val polymorphism and susceptibility to lung cancer: a meta-analysis based on 32 studies. Eur J Cancer Prev 20(6):445–452CrossRefPubMed Wang J, Zheng Y, Sun L, Wang L, Yu P, Li H et al (2011) CYP1A1 Ile462Val polymorphism and susceptibility to lung cancer: a meta-analysis based on 32 studies. Eur J Cancer Prev 20(6):445–452CrossRefPubMed
17.
Zurück zum Zitat Langevin S, Ioannidis J, Vineis P, Taioli E (2010) Assessment of cumulative evidence for the association between glutathione S-transferase polymorphisms and lung cancer: application of the Venice interim guidelines. Pharmacogenet Genomics 20(10):586–597PubMedCentralCrossRefPubMed Langevin S, Ioannidis J, Vineis P, Taioli E (2010) Assessment of cumulative evidence for the association between glutathione S-transferase polymorphisms and lung cancer: application of the Venice interim guidelines. Pharmacogenet Genomics 20(10):586–597PubMedCentralCrossRefPubMed
18.
Zurück zum Zitat Pharoah P, Antoniou A, Bobrow M, Zimmern R, Easton D, Ponder B (2002) Polygenic susceptibility to breast cancer and implications for prevention. Nat Genet 31:33–36CrossRefPubMed Pharoah P, Antoniou A, Bobrow M, Zimmern R, Easton D, Ponder B (2002) Polygenic susceptibility to breast cancer and implications for prevention. Nat Genet 31:33–36CrossRefPubMed
19.
Zurück zum Zitat Kiyohara C, Yoshimasu K, Takayama K, Nakanishi Y (2007) Lung cancer susceptibility: are we on our way to identifying a high-risk group? Future Oncol 3:617–627CrossRefPubMed Kiyohara C, Yoshimasu K, Takayama K, Nakanishi Y (2007) Lung cancer susceptibility: are we on our way to identifying a high-risk group? Future Oncol 3:617–627CrossRefPubMed
20.
Zurück zum Zitat Fletcher O, Houlston R (2010) Architecture of inherited susceptibility to common cancer. Nat Rev Cancer 10:353–361CrossRefPubMed Fletcher O, Houlston R (2010) Architecture of inherited susceptibility to common cancer. Nat Rev Cancer 10:353–361CrossRefPubMed
21.
Zurück zum Zitat Pérez-Morales R, Méndez Ramírez I, Castro Hernández C, Martínez-Ramírez O, Gonsebatt M, Rubio J (2011) Polymorphisms associated with the risk of lung cancer in a healthy Mexican Mestizo population: application of the additive model for cancer. Genet Mol Biol 34(4):546–552PubMedCentralCrossRefPubMed Pérez-Morales R, Méndez Ramírez I, Castro Hernández C, Martínez-Ramírez O, Gonsebatt M, Rubio J (2011) Polymorphisms associated with the risk of lung cancer in a healthy Mexican Mestizo population: application of the additive model for cancer. Genet Mol Biol 34(4):546–552PubMedCentralCrossRefPubMed
22.
Zurück zum Zitat Wacholder S, Chanock S, Garcia-Closas M, El ghormli L, Rothman N (2004) Assessing the probability that a positive report is false: an approach for molecular epidemiology studies. J Nat Cancer Inst 96(6):434–442CrossRefPubMed Wacholder S, Chanock S, Garcia-Closas M, El ghormli L, Rothman N (2004) Assessing the probability that a positive report is false: an approach for molecular epidemiology studies. J Nat Cancer Inst 96(6):434–442CrossRefPubMed
23.
Zurück zum Zitat Hassett C, Aicher L, Sidhu J, Omiecinski C (1994) Human microsomal epoxide hydrolase: genetic polymorphism and functional expression in vitro of aminoacid variants. Human Mol Genet 3(3):421–428CrossRef Hassett C, Aicher L, Sidhu J, Omiecinski C (1994) Human microsomal epoxide hydrolase: genetic polymorphism and functional expression in vitro of aminoacid variants. Human Mol Genet 3(3):421–428CrossRef
24.
Zurück zum Zitat Llorca J, Prieto-Salceda D, Combarros D, Dierssen-Sotosa T, Berciano J (2005) Riesgos competitivos de muerte y equilibrio de Hardy-Weinberg en estudios de casos y controles sobre asociación entre genes y enfermedades. GacSanit 19(4):321–324 Llorca J, Prieto-Salceda D, Combarros D, Dierssen-Sotosa T, Berciano J (2005) Riesgos competitivos de muerte y equilibrio de Hardy-Weinberg en estudios de casos y controles sobre asociación entre genes y enfermedades. GacSanit 19(4):321–324
25.
Zurück zum Zitat Gelhaus S, Harvey R, Penning T, Blair I (2011) Regulation of benzo[a]pyrene-mediated DNA- and glutathione-adduct formation by 2,3,7,8-tetrachlorodibenzo-p-dioxin in human lung cells. Chem Res Toxicol 24(1):89–98PubMedCentralCrossRefPubMed Gelhaus S, Harvey R, Penning T, Blair I (2011) Regulation of benzo[a]pyrene-mediated DNA- and glutathione-adduct formation by 2,3,7,8-tetrachlorodibenzo-p-dioxin in human lung cells. Chem Res Toxicol 24(1):89–98PubMedCentralCrossRefPubMed
26.
Zurück zum Zitat Ferecatu I, Borot M, Bossard C, Leroux M, Boggetto N, Marano F (2010) Polycyclic aromatic hydrocarbon components contribute to the mitochondria-antiapoptotic effect of fine particulate matter on human bronchial epithelial cells via the aryl hydrocarbon receptor. Part Fibre Toxicol 7:18PubMedCentralCrossRefPubMed Ferecatu I, Borot M, Bossard C, Leroux M, Boggetto N, Marano F (2010) Polycyclic aromatic hydrocarbon components contribute to the mitochondria-antiapoptotic effect of fine particulate matter on human bronchial epithelial cells via the aryl hydrocarbon receptor. Part Fibre Toxicol 7:18PubMedCentralCrossRefPubMed
27.
Zurück zum Zitat Koyano S, Saito Y, Fukushima-Uesaka H, Ishida S, Ozawa S, Kamatani N (2005) Functional analysis of six human aryl hydrocarbon receptor variants in a Japanese population. Drug Metab Dispos 33(8):1254–1260CrossRefPubMed Koyano S, Saito Y, Fukushima-Uesaka H, Ishida S, Ozawa S, Kamatani N (2005) Functional analysis of six human aryl hydrocarbon receptor variants in a Japanese population. Drug Metab Dispos 33(8):1254–1260CrossRefPubMed
28.
Zurück zum Zitat Celius T, Matthews J (2010) Functional analysis of six human aryl hydrocarbon receptor variants in human breast cancer and mouse hepatoma cell lines. Toxicology 277(1–3):59–65CrossRefPubMed Celius T, Matthews J (2010) Functional analysis of six human aryl hydrocarbon receptor variants in human breast cancer and mouse hepatoma cell lines. Toxicology 277(1–3):59–65CrossRefPubMed
29.
Zurück zum Zitat Gelhaus S, Gilad O, Hwang W, Penning T, Blair I (2012) Multidrug resistance protein (MRP) 4 attenuates benzo[a]pyrene-mediated DNA-adduct formation in human bronchoalveolar H358 cells. Toxicol Lett 209(1):58–66PubMedCentralCrossRefPubMed Gelhaus S, Gilad O, Hwang W, Penning T, Blair I (2012) Multidrug resistance protein (MRP) 4 attenuates benzo[a]pyrene-mediated DNA-adduct formation in human bronchoalveolar H358 cells. Toxicol Lett 209(1):58–66PubMedCentralCrossRefPubMed
30.
Zurück zum Zitat Qiuling S, Yuxin Z, Suhua Z, Cheng X, Shuguang L, Fengsheng H (2003) Cyclin D1 gene polymorphism and susceptibility to lung cancer in a Chinese population. Carcinogenesis 24(9):1499–1503CrossRefPubMed Qiuling S, Yuxin Z, Suhua Z, Cheng X, Shuguang L, Fengsheng H (2003) Cyclin D1 gene polymorphism and susceptibility to lung cancer in a Chinese population. Carcinogenesis 24(9):1499–1503CrossRefPubMed
31.
Zurück zum Zitat Sobti R, Kaur P, Kaur S, Singh J, Janmeja A, Jindal S (2006) Effects of cyclin D1 (CCND1) polymorphism on susceptibility to lung cancer in a North Indian population. Cancer Genet Cytogenet 170(2):108–114CrossRefPubMed Sobti R, Kaur P, Kaur S, Singh J, Janmeja A, Jindal S (2006) Effects of cyclin D1 (CCND1) polymorphism on susceptibility to lung cancer in a North Indian population. Cancer Genet Cytogenet 170(2):108–114CrossRefPubMed
32.
Zurück zum Zitat Sofer-Levi Y, Resnitzky D (1996) Apoptosis induced by ectopic expression of cyclin D1 but not cyclin E. Oncogene 13(11):2431–2437PubMed Sofer-Levi Y, Resnitzky D (1996) Apoptosis induced by ectopic expression of cyclin D1 but not cyclin E. Oncogene 13(11):2431–2437PubMed
Metadaten
Titel
Genetic Susceptibility to Lung Cancer Based on Candidate Genes in a Sample from the Mexican Mestizo Population: A Case–Control Study
verfasst von
R. Pérez-Morales
I. Méndez-Ramírez
H. Moreno-Macias
A. D. Mendoza-Posadas
O. C. Martínez-Ramírez
C. Castro-Hernández
M. E. Gonsebatt
J. Rubio
Publikationsdatum
01.02.2014
Verlag
Springer US
Erschienen in
Lung / Ausgabe 1/2014
Print ISSN: 0341-2040
Elektronische ISSN: 1432-1750
DOI
https://doi.org/10.1007/s00408-013-9536-7

Weitere Artikel der Ausgabe 1/2014

Lung 1/2014 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.